Alex Advani, PhD

Alex Advani has spent his consulting career applying his deep analytical experience and skills to biopharmaceutical strategy. His work includes launch strategy, site of care and account profiling, opportunity assessment, indication prioritization, and portfolio development strategy. He has deep expertise in multiple therapeutic areas such as solid tumors and hematology/oncology, genetic and rare disease, and immunology. Alex received Ph.D. and Master’s degrees in Genetics, Genomics, and Systems Biology from the University of Chicago and a B.A. in Biology from Duke University.